Selatogrel
ID-076A201
Phase 2 small_molecule completed
Quick answer
Selatogrel for Stable Coronary Artery Disease is a Phase 2 program (small_molecule) at Viatris Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Viatris Pharmaceuticals Co.,
- Indication
- Stable Coronary Artery Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed